Piperidine, 1-(1-oxo-3-phenyl-2-propenyl)-

Details

Top
Internal ID 706d3d79-0460-41e4-b84d-b0af34415988
Taxonomy Phenylpropanoids and polyketides > Cinnamic acids and derivatives
IUPAC Name 3-phenyl-1-piperidin-1-ylprop-2-en-1-one
SMILES (Canonical) C1CCN(CC1)C(=O)C=CC2=CC=CC=C2
SMILES (Isomeric) C1CCN(CC1)C(=O)C=CC2=CC=CC=C2
InChI InChI=1S/C14H17NO/c16-14(15-11-5-2-6-12-15)10-9-13-7-3-1-4-8-13/h1,3-4,7-10H,2,5-6,11-12H2
InChI Key KNOXUMZPTHELAO-UHFFFAOYSA-N
Popularity 13 references in papers

Physical and Chemical Properties

Top
Molecular Formula C14H17NO
Molecular Weight 215.29 g/mol
Exact Mass 215.131014166 g/mol
Topological Polar Surface Area (TPSA) 20.30 Ų
XlogP 2.70
Atomic LogP (AlogP) 2.71
H-Bond Acceptor 1
H-Bond Donor 0
Rotatable Bonds 2

Synonyms

Top
MLS002638142
cinnamoylpiperidine
1-cinnamoyl piperidine
CBDivE_013760
CHEMBL1703375
KNOXUMZPTHELAO-UHFFFAOYSA-N
HMS3093I04
NCI60_000099
SMR001547632

2D Structure

Top
2D Structure of Piperidine, 1-(1-oxo-3-phenyl-2-propenyl)-

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9834 98.34%
Caco-2 + 0.9238 92.38%
Blood Brain Barrier + 0.9750 97.50%
Human oral bioavailability + 0.6143 61.43%
Subcellular localzation Mitochondria 0.4447 44.47%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9683 96.83%
OATP1B3 inhibitior + 0.9516 95.16%
MATE1 inhibitior - 0.8600 86.00%
OCT2 inhibitior + 0.7500 75.00%
BSEP inhibitior - 0.7276 72.76%
P-glycoprotein inhibitior - 0.9649 96.49%
P-glycoprotein substrate - 0.9547 95.47%
CYP3A4 substrate - 0.7247 72.47%
CYP2C9 substrate - 0.7817 78.17%
CYP2D6 substrate - 0.8309 83.09%
CYP3A4 inhibition - 0.7406 74.06%
CYP2C9 inhibition - 0.5971 59.71%
CYP2C19 inhibition + 0.8722 87.22%
CYP2D6 inhibition - 0.7472 74.72%
CYP1A2 inhibition + 0.5643 56.43%
CYP2C8 inhibition - 0.8579 85.79%
CYP inhibitory promiscuity + 0.6363 63.63%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9300 93.00%
Carcinogenicity (trinary) Non-required 0.5375 53.75%
Eye corrosion - 0.9230 92.30%
Eye irritation + 0.8128 81.28%
Skin irritation + 0.6048 60.48%
Skin corrosion - 0.8661 86.61%
Ames mutagenesis - 0.9200 92.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7294 72.94%
Micronuclear - 0.6200 62.00%
Hepatotoxicity + 0.6118 61.18%
skin sensitisation - 0.8850 88.50%
Respiratory toxicity + 0.7778 77.78%
Reproductive toxicity + 0.5667 56.67%
Mitochondrial toxicity + 0.8750 87.50%
Nephrotoxicity - 0.7970 79.70%
Acute Oral Toxicity (c) III 0.5937 59.37%
Estrogen receptor binding - 0.6674 66.74%
Androgen receptor binding + 0.5888 58.88%
Thyroid receptor binding - 0.6071 60.71%
Glucocorticoid receptor binding - 0.7217 72.17%
Aromatase binding + 0.8062 80.62%
PPAR gamma - 0.7737 77.37%
Honey bee toxicity - 0.9802 98.02%
Biodegradation - 0.6000 60.00%
Crustacea aquatic toxicity - 0.6300 63.00%
Fish aquatic toxicity - 0.5332 53.32%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 94.51% 95.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 92.76% 86.33%
CHEMBL2581 P07339 Cathepsin D 91.18% 98.95%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 89.27% 96.00%
CHEMBL1293255 P15428 15-hydroxyprostaglandin dehydrogenase [NAD+] 88.39% 83.57%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.07% 96.09%
CHEMBL5028 O14672 ADAM10 86.52% 97.50%
CHEMBL3192 Q9BY41 Histone deacetylase 8 83.32% 93.99%
CHEMBL4208 P20618 Proteasome component C5 81.02% 90.00%
CHEMBL5805 Q9NR97 Toll-like receptor 8 80.98% 96.25%

Cross-Links

Top
PubChem 223147
NPASS NPC305602
LOTUS LTS0108963
wikiData Q105143500